Phenol-containing compound biosynthetic process

pathway activity — cross-omics
GO:0046189Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Phenol-containing compound biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are MMS22L, CEP162, and CDKAL1, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Phenol-containing compound biosynthetic process activity versus MMS22L in LUAD (Pearson r = -0.09).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADMMS22L →-0.321-0.589.002.00234
LUADCEP162 →-0.293-0.503.002.00633
LUADCDKAL1 →-0.273-0.490<.001.00133
LUADUHRF2 →-0.310-0.595.001.00133
LUADCEP78 →-0.250-0.449.003.00433
LUADTEX30 →-0.369-0.500<.001.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0046189 vs MMS22L — LUAD

Per-sample scatter of Phenol-containing compound biosynthetic process activity vs MMS22L in LUAD.

Explore this scatter interactively →

Exploration